🇺🇸 FDA
Patent

US 6261841

Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells

expired A61KA61K2035/124

Quick answer

US patent 6261841 (Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells) held by The Board of Trustees of Northwestern University expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Trustees of Northwestern University
Grant date
Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2035/124